AU5568290A - Method of suppressing hiv infection - Google Patents

Method of suppressing hiv infection

Info

Publication number
AU5568290A
AU5568290A AU55682/90A AU5568290A AU5568290A AU 5568290 A AU5568290 A AU 5568290A AU 55682/90 A AU55682/90 A AU 55682/90A AU 5568290 A AU5568290 A AU 5568290A AU 5568290 A AU5568290 A AU 5568290A
Authority
AU
Australia
Prior art keywords
hiv infection
suppressing hiv
suppressing
infection
hiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU55682/90A
Inventor
Donald C. Anderson
Robert J. Eckner
Roger D. Rossen
Robert Rothlein
C. Wayne Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baylor College of Medicine
Boehringer Ingelheim Pharmaceuticals Inc
Original Assignee
Baylor College of Medicine
Boehringer Ingelheim Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College of Medicine, Boehringer Ingelheim Pharmaceuticals Inc filed Critical Baylor College of Medicine
Publication of AU5568290A publication Critical patent/AU5568290A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/70553—Integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU55682/90A 1989-04-28 1990-04-27 Method of suppressing hiv infection Abandoned AU5568290A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34486889A 1989-04-28 1989-04-28
US344868 1999-06-28

Publications (1)

Publication Number Publication Date
AU5568290A true AU5568290A (en) 1990-11-29

Family

ID=23352400

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55682/90A Abandoned AU5568290A (en) 1989-04-28 1990-04-27 Method of suppressing hiv infection

Country Status (3)

Country Link
AU (1) AU5568290A (en)
WO (1) WO1990013281A2 (en)
ZA (1) ZA903258B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991018010A1 (en) * 1990-05-15 1991-11-28 Swinburne Limited Inhibition of viral infection using intercellular adhesion molecule-1-like peptides and/or analogues thereof

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6129916A (en) * 1991-04-19 2000-10-10 Tanox, Inc. Method of Increasing activation on proliferation of T cells using antibody-microbead conjugates
CA2065658A1 (en) * 1991-04-19 1992-10-20 Tse-Wen Chang Conjugates of liposomes or microbeads and antibodies specific for t lymphocytes and their use in vivo immune modulators
US6197298B1 (en) 1991-04-19 2001-03-06 Tanox, Inc. Modified binding molecules specific for T lymphocytes and their use as in vivo immune modulators in animals
US5872222A (en) * 1991-04-19 1999-02-16 Tanox Biosystems, Inc. Conjugates of polymers and antibodies specific for T lymphocytes, and their use as adjuvants
US6106835A (en) * 1991-04-19 2000-08-22 Tanox, Inc. Modified binding molecules specific for T or B lymphocytes and their use as in vivo immune modulators
US6534057B2 (en) * 1993-03-19 2003-03-18 Allen D. Allen Method increasing the delayed-type hypersensitivity response by infusing LFA-1-specific antibodies
AU6256796A (en) * 1995-06-06 1996-12-24 D. Allen Allen Method for treating molluscum contagiosum resulting from hiv infection
DE60042069D1 (en) 1999-06-24 2009-06-04 Univ Johns Hopkins COMPOSITIONS AND METHODS FOR PREVENTING TRANSPITHELIAL TRANSMISSION OF HIV
JP2008507592A (en) 2004-06-09 2008-03-13 ジェネンテック・インコーポレーテッド Treatment of annular granulomas or sarcoids
WO2007047573A2 (en) * 2005-10-14 2007-04-26 The Johns Hopkins School Of Medicine Reduction and prevention of cell-associated hiv transepithelial migration, microbides and other formulations and methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0303692A4 (en) * 1987-02-26 1990-12-05 Dana Farber Cancer Institute Cloning of lfa-1
ES2080044T3 (en) * 1987-05-04 1996-02-01 Dana Farber Cancer Inst Inc INTERCELLULAR ADHESION MOLECULES AND THEIR FIXATION LINKS.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991018010A1 (en) * 1990-05-15 1991-11-28 Swinburne Limited Inhibition of viral infection using intercellular adhesion molecule-1-like peptides and/or analogues thereof

Also Published As

Publication number Publication date
ZA903258B (en) 1991-02-27
WO1990013281A3 (en) 2004-04-22
WO1990013281A2 (en) 1990-11-15

Similar Documents

Publication Publication Date Title
AU1952288A (en) Method of selectively inhibiting hiv
AU3028592A (en) Method of preparing rib-bearing article
AU6822990A (en) Hiv protease inhibitors useful for the treatment of aids
AU600264B2 (en) Treatment of fungal infections
AU7786387A (en) Composition of matter and method of immunizing against viral causative agents of aids and arc
AU619968B2 (en) Novel method and compounds
AU3413389A (en) Method of treating retrovirus infection
AU5568290A (en) Method of suppressing hiv infection
AU8012387A (en) Method of painting
AU5564590A (en) Infection barrier
AU1193988A (en) Method of inhibiting the transmission of aids virus
AU6660090A (en) Treatment of depression
AU582303B2 (en) Method of curve approximation
AU5627290A (en) Method of making optical devices
AU3836489A (en) Treatment of immunodeficiency
AU2473695A (en) Method of slowing the progression of hiv infection
AU6674290A (en) Methods of treating retroviral infection
AU6357890A (en) Expression of alpha-macroglobulins
AU7713387A (en) Hepatitis vaccine
AU2759188A (en) Method of manufacturing ceramic artifact
AU5689190A (en) Method of preparing n-oxo-tetrahydro-beta-carbolines
AU6877991A (en) A method of inactivating human immunodeficiency virus
AU2414992A (en) Method of combatting hiv infections
AU4958690A (en) Preparation of 2-halofluorobenzene
AU5632590A (en) Method of inactivating lipase